1.80
price up icon2.27%   0.04
after-market Handel nachbörslich: 1.80
loading

Protalix BioTherapeutics Inc. Aktie (PLX) Neueste Nachrichten

pulisher
Dec 18, 2025

Protalix, Secarna in agreement to develop rare kidney disorder therapies - MSN

Dec 18, 2025
pulisher
Dec 17, 2025

Small cap wrap: Tiziana Life Sciences, NanoViricides, 1911 Gold, Protalix BioTherapeutics… - Proactive Investors

Dec 17, 2025
pulisher
Dec 17, 2025

Protalix and Secarna partner to develop rare kidney disease treatments By Investing.com - Investing.com Nigeria

Dec 17, 2025
pulisher
Dec 17, 2025

Protalix BioTherapeutics (PLX) Partners with Secarna for Kidney Disorder Treatments - GuruFocus

Dec 17, 2025
pulisher
Dec 17, 2025

Protalix BioTherapeutics partners with Secarna Pharmaceuticals on rare kidney disease drug development - Proactive financial news

Dec 17, 2025
pulisher
Dec 17, 2025

Protalix Partners With Secarna to Jointly Develop Therapies for Rare Renal Indications - marketscreener.com

Dec 17, 2025
pulisher
Dec 17, 2025

Protalix and Secarna partner to develop rare kidney disease treatments - Investing.com

Dec 17, 2025
pulisher
Dec 17, 2025

Protalix Biotherapeutics and Secarna Pharmaceuticals enter into collaboration and option agreement - marketscreener.com

Dec 17, 2025
pulisher
Dec 17, 2025

Protalix Biotherapeutics and Secarna Pharmaceuticals Enter into Collaboration and Option Agreement - PR Newswire

Dec 17, 2025
pulisher
Dec 05, 2025

Protalix BioTherapeutics (PLX) Price Target Decreased by 10.71% to 12.75 - Nasdaq

Dec 05, 2025
pulisher
Dec 05, 2025

Why analysts recommend Protalix BioTherapeutics Inc. (PBDA) stockJuly 2025 Selloffs & Detailed Earnings Play Strategies - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Will Protalix BioTherapeutics Inc. (PBDA) stock rise with strong economy2025 Analyst Calls & Capital Protection Trading Alerts - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

How Protalix BioTherapeutics Inc. (DE) stock performs in volatility spikes2025 Short Interest & Growth Oriented Trading Recommendations - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Why global investors buy Protalix BioTherapeutics Inc. (DE) stockMarket Sentiment Summary & Technical Entry and Exit Tips - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Is Protalix BioTherapeutics Inc. (PBDA) stock a contrarian opportunity - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Will Protalix BioTherapeutics Inc. (DE) stock split increase liquidityJuly 2025 Snapshot & Low Drawdown Momentum Trade Ideas - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Why Protalix BioTherapeutics Inc. (DE) stock attracts wealthy investors2025 Market Trends & Scalable Portfolio Growth Methods - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Is Protalix BioTherapeutics Inc. (DE) stock supported by strong fundamentals2025 Volume Leaders & Technical Confirmation Trade Alerts - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

How Protalix BioTherapeutics Inc. (PBDA) stock behaves under inflation pressure2025 Bull vs Bear & Verified Entry Point Detection - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

How Protalix BioTherapeutics Inc. (PBDA) stock compares with top peersJuly 2025 Selloffs & Short-Term High Return Ideas - Newser

Dec 03, 2025
pulisher
Dec 02, 2025

Protalix BioTherapeutics (PLX) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025
pulisher
Dec 02, 2025

Will Protalix BioTherapeutics Inc. (DE) stock test record highs in 2025Weekly Trade Recap & Risk Controlled Swing Alerts - Newser

Dec 02, 2025
pulisher
Nov 30, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review

Nov 30, 2025
pulisher
Nov 29, 2025

Sentiment Watch: Is Protalix BioTherapeutics Inc. stock attractive for hedge fundsCPI Data & AI Based Buy and Sell Signals - moha.gov.vn

Nov 29, 2025
pulisher
Nov 25, 2025

Protalix BioTherapeutics Inc. R (PBDA.F) Q1 FY2025 earnings call transcript - Yahoo Finance

Nov 25, 2025
pulisher
Nov 25, 2025

Protalix BioTherapeutics Inc. R (PBDA.F) Q2 FY2025 earnings call transcript - Yahoo Finance

Nov 25, 2025
pulisher
Nov 24, 2025

Research Analysts Set Expectations for PLX FY2025 Earnings - Defense World

Nov 24, 2025
pulisher
Nov 23, 2025

HC Wainwright Lowers Protalix BioTherapeutics (NYSE:PLX) Price Target to $12.00 - Defense World

Nov 23, 2025
pulisher
Nov 21, 2025

PLX Analyst Forecasts - Quiver Quantitative

Nov 21, 2025
pulisher
Nov 21, 2025

Protalix BioTherapeutics (PLX) Price Target Lowered by HC Wainwr - GuruFocus

Nov 21, 2025
pulisher
Nov 21, 2025

HC Wainwright & Co. Maintains Protalix BioTherapeutics (PLX) Buy Recommendation - Nasdaq

Nov 21, 2025
pulisher
Nov 21, 2025

Can Protalix BioTherapeutics Inc. (PBDA) stock sustain double digit ROEJuly 2025 Pullbacks & Weekly High Conviction Trade Ideas - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Is Protalix BioTherapeutics Inc. stock undervalued vs historical averagesQuarterly Profit Summary & Long Hold Capital Preservation Tips - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Zacks Small Cap Has Bearish Outlook for PLX FY2025 Earnings - Defense World

Nov 20, 2025
pulisher
Nov 20, 2025

What RSI levels show for Protalix BioTherapeutics Inc. (PBDA) stockJuly 2025 Fed Impact & Advanced Technical Signal Analysis - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Will Protalix BioTherapeutics Inc. stock maintain dividend yieldJuly 2025 Decliners & Daily Entry Point Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

PLX: Protalix Seeks Re-Examination of CHMP Opinion - MSN

Nov 19, 2025
pulisher
Nov 19, 2025

How to integrate Protalix BioTherapeutics Inc. into portfolio analysis toolsEarnings Summary Report & Safe Capital Growth Stock Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

[Form 4] Protalix BioTherapeutics, Inc. Insider Trading Activity - Stock Titan

Nov 19, 2025
$38.43
price up icon 0.31%
$97.31
price down icon 0.33%
$31.50
price down icon 0.66%
$91.46
price down icon 0.15%
biotechnology ONC
$307.02
price up icon 0.32%
$166.55
price down icon 16.08%
Kapitalisierung:     |  Volumen (24h):